{"disease":{"id":"ovarian-stimulation","name":"ovarian stimulation"},"drugs":{"marketed":[{"drug_id":"clomifene","indication_name":"Controlled ovarian stimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Clomid","generic_name":"clomifene","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase","drug_class":"Estrogen Agonist/Antagonist","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"norethisterone","indication_name":"Controlled ovarian stimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Micronor","generic_name":"norethisterone","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"GnRH receptors","drug_class":"Progestin","quality_score":63,"revenue":null,"mechanism":"ORIAHNN combines elagolix, which suppresses LH and FSH to reduce ovarian sex hormones, with estradiol and norethindrone acetate to mitigate side effects."},{"drug_id":"dostinex","indication_name":"Prevention of ovarian hyperstimulation syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Dostinex","company_name":"Par Pharmaceutical, Inc.","drug_phase":"phase_1","molecular_target":"D(1B) dopamine receptor, D(4) dopamine receptor, 5-hydroxytryptamine receptor 1A","drug_class":"","quality_score":27,"revenue":null,"mechanism":null},{"drug_id":"cetrorelix","indication_name":"Prevention of premature ovulation during controlled ovarian stimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cetrotide","generic_name":"CETRORELIX","company_name":"Merck KGaA","drug_phase":"marketed","molecular_target":"Gonadotropin-releasing hormone receptor","drug_class":"Gonadotropin Releasing Hormone Receptor Antagonist","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"estradiol","indication_name":"Controlled ovarian stimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estrace","generic_name":"ESTRADIOL","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"Estrogen","quality_score":10,"revenue":null,"mechanism":"Estrace works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen."},{"drug_id":"medroxyprogesterone","indication_name":"Prevention of premature ovulation during controlled ovarian stimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Depo-Provera","generic_name":"medroxyprogesterone","company_name":"Pfizer","drug_phase":"discontinued","molecular_target":"Progesterone receptor","drug_class":"Progestin","quality_score":null,"revenue":null,"mechanism":"Depo-Provera works by binding to the progesterone receptor in the body, which helps to regulate the menstrual cycle and prevent pregnancy."},{"drug_id":"ganirelix","indication_name":"Prevention of Luteinizing Hormone Surge when undergoing Controlled Ovarian Hyperstimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ganirelix Acetate","generic_name":"GANIRELIX","company_name":"Organon Usa Organon","drug_phase":"marketed","molecular_target":"Gonadotropin-releasing hormone receptor","drug_class":"Gonadotropin Releasing Hormone Receptor Antagonist","quality_score":46,"revenue":null,"mechanism":""},{"drug_id":"dydrogesterone","indication_name":"Prevention of premature ovulation during controlled ovarian stimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Gynorest","generic_name":"DYDROGESTERONE","company_name":"Solvay","drug_phase":"marketed","molecular_target":"Progesterone receptor","drug_class":"dydrogesterone","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"metformin","indication_name":"Controlled ovarian stimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Glucophage","generic_name":"metformin","company_name":"Generic (originally Merck Serono/Lipha)","drug_phase":"marketed","molecular_target":"5'-AMP-activated protein kinase subunit beta-1, Solute carrier family 22 member 1, Solute carrier family 22 member 2","drug_class":"Dipeptidyl Peptidase 4 Inhibitor [EPC]","quality_score":55,"revenue":null,"mechanism":"Activates AMP-activated protein kinase (AMPK) to reduce hepatic glucose production and improve insulin sensitivity without causing hypoglycemia."},{"drug_id":"clomid","indication_name":"Controlled ovarian stimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Clomid","company_name":"rana alaaeldin aly ibrahim nasr","drug_phase":"phase_1","molecular_target":"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase, 5-hydroxytryptamine receptor 6, Adenosine receptor A3","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"levonorgestrel","indication_name":"Controlled ovarian stimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Jadelle","generic_name":"LEVONORGESTREL","company_name":"Fdn Consumer","drug_phase":"marketed","molecular_target":"Progesterone receptor","drug_class":"Progestin","quality_score":10,"revenue":null,"mechanism":"Jadelle works by binding to the progesterone receptor, which helps to prevent ovulation and thicken cervical mucus to prevent sperm from reaching the egg."},{"drug_id":"cetrotide","indication_name":"Prevention of premature ovulation during controlled ovarian stimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cetrotide","company_name":"Wolfson Medical Center","drug_phase":"marketed","molecular_target":"Gonadotropin-releasing hormone receptor, Lutropin-choriogonadotropic hormone receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"glucophage","indication_name":"Controlled ovarian stimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Glucophage","company_name":"Dr. Reddy's Laboratories Limited","drug_phase":"marketed","molecular_target":"5'-AMP-activated protein kinase subunit beta-1, Solute carrier family 22 member 1, Solute carrier family 22 member 2","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ethinylestradiol","indication_name":"Controlled ovarian stimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ortho-Novum 10/11-21","generic_name":"Ethinylestradiol","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"Estrogen","quality_score":38,"revenue":null,"mechanism":""},{"drug_id":"estring","indication_name":"Controlled ovarian stimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estring","generic_name":"Estradiol","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Ovulation","drug_class":"Combined Oral Contraceptive (COC)","quality_score":71,"revenue":null,"mechanism":"Prevents pregnancy primarily by suppressing ovulation."},{"drug_id":"femara","indication_name":"Controlled ovarian stimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Femara","company_name":"M.D. Anderson Cancer Center","drug_phase":"discontinued","molecular_target":"Cytochrome P450 11B2, mitochondrial, Aromatase, Cytochrome P450 11B1, mitochondrial","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"letrozole","indication_name":"Controlled ovarian stimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Femara","generic_name":"letrozole","company_name":"Novartis AG","drug_phase":"marketed","molecular_target":"aromatase enzyme","drug_class":"Aromatase Inhibitor [EPC]","quality_score":65,"revenue":null,"mechanism":"Letrozole reduces estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogens."},{"drug_id":"cabergoline","indication_name":"Prevention of ovarian hyperstimulation syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dostinex","generic_name":"CABERGOLINE","company_name":"Pfizer Japan Inc.","drug_phase":"marketed","molecular_target":"D(2) dopamine receptor","drug_class":"Ergot Derivative [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"drospirenone","indication_name":"Controlled ovarian stimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Slynd","generic_name":"DROSPIRENONE","company_name":"Exeltis Usa Inc","drug_phase":"marketed","molecular_target":"Mineralocorticoid receptor","drug_class":"Progestin","quality_score":75,"revenue":null,"mechanism":"Slynd works by binding to the mineralocorticoid receptor, a protein that plays a role in hormone regulation."},{"drug_id":"chorionic-gonadotrophin","indication_name":"Controlled ovarian stimulation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Choriogonadotropin","generic_name":"chorionic gonadotrophin","company_name":"Ferring","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":19,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":20,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05362734","title":"Freeze All Strategy Versus Fresh Embryo Transfer After GnRH Analogue Trigger","phase":"","overall_status":"COMPLETED","enrollment_count":1396,"lead_sponsor_name":"Istituto Clinico Humanitas","has_results":false},{"nct_id":"NCT03393780","title":"Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures","phase":"","overall_status":"COMPLETED","enrollment_count":1018,"lead_sponsor_name":"Ferring Pharmaceuticals","has_results":false},{"nct_id":"NCT07457684","title":"Comparison of Follitropin Delta and Follitropin Alfa in Combination With Menotropin","phase":"","overall_status":"COMPLETED","enrollment_count":846,"lead_sponsor_name":"Clinique Ovo","has_results":false},{"nct_id":"NCT06378268","title":"PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":626,"lead_sponsor_name":"Mỹ Đức Hospital","has_results":false},{"nct_id":"NCT03564509","title":"A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":620,"lead_sponsor_name":"Ferring Pharmaceuticals","has_results":false},{"nct_id":"NCT04414748","title":"Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Patients Undergoing PGT-A","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"ShangHai Ji Ai Genetics & IVF Institute","has_results":false},{"nct_id":"NCT03697031","title":"Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE®","phase":"","overall_status":"TERMINATED","enrollment_count":362,"lead_sponsor_name":"Ferring Pharmaceuticals","has_results":false},{"nct_id":"NCT05994378","title":"To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Female Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":317,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT06739759","title":"Ovarian Hyperstimulation Syndrome Prevention","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Aljazeera Hospital","has_results":false},{"nct_id":"NCT03996434","title":"Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"ClinAmygate","has_results":false},{"nct_id":"NCT04576546","title":"Inositols and FSH in IVF","phase":"NA","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Lo.Li.Pharma s.r.l","has_results":false},{"nct_id":"NCT00988260","title":"Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":266,"lead_sponsor_name":"Organon and Co","has_results":false},{"nct_id":"NCT04503707","title":"Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice","phase":"","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"Ferring Pharmaceuticals","has_results":false},{"nct_id":"NCT03473613","title":"Cabergoline Versus Calcium Infusion in Ovarian Hyperstimulation Syndrome Prevention","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"Benha University","has_results":false},{"nct_id":"NCT05326087","title":"Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":204,"lead_sponsor_name":"ShangHai Ji Ai Genetics & IVF Institute","has_results":false},{"nct_id":"NCT05499052","title":"Trial to Assess the Pattern of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation (IVF) or Intracytoplasmic Sperm Injection (ICSI) Procedures in Routine Clinical Practice","phase":"","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Ferring Pharmaceuticals","has_results":false},{"nct_id":"NCT05198128","title":"Ovarian Hyperstimulation Syndrome Using Calcium Infusion","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Al-Azhar University","has_results":false},{"nct_id":"NCT05166668","title":"Letrozole /GnRH Antagonist Protocol in Women Over 40 Years Undergoing ICSI Cycle","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Menoufia University","has_results":false},{"nct_id":"NCT03939403","title":"Conventional Ovarian Stimulation vs. Single Injection Stimulation of Corifollitropin Alfa in Oocyte Donor","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Instituto Bernabeu","has_results":false},{"nct_id":"NCT06333691","title":"Comparative Study Between Calcium Gluconate With Diosmin, Cabergoline and Cabergoline With Diosmin","phase":"NA","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Minia University","has_results":false},{"nct_id":"NCT05588635","title":"Association Between Live Birth Rate and Serum Progesterone During Hormonal Replacement Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Centre Hospitalier Régional Metz-Thionville","has_results":false},{"nct_id":"NCT04175990","title":"IVF Outcome Following Progestogen Ovarian Stimulation","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":155,"lead_sponsor_name":"National University of Malaysia","has_results":false},{"nct_id":"NCT06572930","title":"Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"ART Fertility Clinics LLC","has_results":false},{"nct_id":"NCT07121751","title":"Optimal Stimulation of Hypo-responders Undergoing in Vitro Fertilization (IVF)","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Dunamenti REK Istenhegyi IVF Center","has_results":false},{"nct_id":"NCT02610608","title":"Medical Assistance for the Procreation and Risk of Thrombosis.","phase":"","overall_status":"TERMINATED","enrollment_count":129,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT03400722","title":"Double Ovarian Stimulation as Accumulation Strategy for Older Infertile Patients With Suboptimal Ovarian Response","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Nova Clinic, Russia","has_results":false},{"nct_id":"NCT03876145","title":"The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Royan Institute","has_results":false},{"nct_id":"NCT02738580","title":"Follicular Steroid Genesis in Controlled Ovarian Stimulation","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"Instituto Valenciano de Infertilidad, IVI VALENCIA","has_results":true},{"nct_id":"NCT04351126","title":"Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"Ganin Fertility Center","has_results":false},{"nct_id":"NCT06812559","title":"Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"El Shatby University Hospital for Obstetrics and Gynecology","has_results":false},{"nct_id":"NCT06839274","title":"Follicular Volume at the Time of Final Oocyte Maturation in Poor Responders, and Its Correlation With Oocyte Maturity","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"ART Fertility Clinics LLC","has_results":false},{"nct_id":"NCT04797338","title":"Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Assaf-Harofeh Medical Center","has_results":false},{"nct_id":"NCT04539613","title":"Controlled Ovarian Hyperstimulation (COH) With Sequential HPFSH & HMG Versus Rec-F.S.H Alone in ICSI Cycle","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Alaa Fouli Gaber Ebrahim","has_results":false},{"nct_id":"NCT05638529","title":"Dual Trigger\" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Mount Sinai Hospital, Canada","has_results":false},{"nct_id":"NCT04002141","title":"Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT06175832","title":"PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT01112358","title":"Lutropin Alfa in Women at Risk of Poor Response","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Merck KGaA, Darmstadt, Germany","has_results":true},{"nct_id":"NCT04549649","title":"The Effect of Dual Trigger for Final Oocyte Maturation on IVF/ICSI Outcomes in Patients With Suboptimal Ovarian Response","phase":"NA","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Royan Institute","has_results":false},{"nct_id":"NCT03939390","title":"Follicular Phase Stimulation vs. Luteal Phase Stimulation in Patients Diagnosed With Suboptimal Response","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Instituto Bernabeu","has_results":false},{"nct_id":"NCT06781957","title":"Pharmacokinetics of FSH and hCG After a Single Subcutaneous Injection of Gonadotropins-IBSA","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"IBSA Institut Biochimique SA","has_results":false},{"nct_id":"NCT06659692","title":"Pharmacokinetics of FSH and hCG Following Multiple Dose of Gonadotropins-IBSA.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"IBSA Institut Biochimique SA","has_results":false},{"nct_id":"NCT03366025","title":"Progesterone Variation on the Final Day of Oocyte Maturation.","phase":"","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Fundacion Dexeus","has_results":false},{"nct_id":"NCT02200952","title":"Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS","phase":"","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"San Carlo Public Hospital, Potenza, Italy","has_results":false},{"nct_id":"NCT02975713","title":"Progesterone Diurnal Rhythm During Ovarian Stimulation for IVF","phase":"","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"ART Fertility Clinics LLC","has_results":false},{"nct_id":"NCT03298750","title":"Mechanical Stimulation of the Ovary for Infertility Treatment in Patients With Very Low Ovarian Reserve","phase":"NA","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"Sheba Medical Center","has_results":false},{"nct_id":"NCT06732843","title":"Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?","phase":"","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"ART Fertility Clinics LLC","has_results":false},{"nct_id":"NCT02701452","title":"Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response","phase":"NA","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT01109888","title":"Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS)","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Wolfson Medical Center","has_results":false},{"nct_id":"NCT00365027","title":"Transfer of Fresh Versus Frozen/Thawed Embryos in IVF Cycles Where GnRH Agonist is Utilized for Oocyte Maturation.","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"HaEmek Medical Center, Israel","has_results":false}],"total":49},"guidelines":[],"source":"Drug Landscape verified database"}